Fernandes, Ricardo A. http://orcid.org/0000-0001-5343-3334
Su, Leon http://orcid.org/0000-0001-7654-9997
Nishiga, Yoko
Ren, Junming
Bhuiyan, Aladdin M. http://orcid.org/0000-0002-5958-2397
Cheng, Ning
Kuo, Calvin J. http://orcid.org/0000-0002-7427-5985
Picton, Lora K.
Ohtsuki, Shozo http://orcid.org/0000-0001-8954-5709
Majzner, Robbie G. http://orcid.org/0000-0001-6969-8011
Rietberg, Skyler P.
Mackall, Crystal L. http://orcid.org/0000-0001-6323-4304
Yin, Qian
Ali, Lestat R. http://orcid.org/0000-0003-2673-1592
Yang, Xinbo
Savvides, Christina S.
Sage, Julien http://orcid.org/0000-0002-8928-9968
Dougan, Michael
Garcia, K. Christopher http://orcid.org/0000-0001-9273-0278
Article History
Received: 21 June 2019
Accepted: 24 July 2020
First Online: 21 October 2020
Competing interests
: RIPR is the subject of a pending patent application (63/056,156), with K.C.G. and R.A.F. listed as inventors. K.C.G. is the founder of Synthekine Therapeutics Inc.